ARCHIVES

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

Risk of Lymphoma Increases with Hepatitis C Virus Infection

May 25, 2007

Cancer Groups Support Senate FDA Bill; Reform Measure Face Uncertain future

March 1, 1996

Doubling Budget For NSF High Priority For FASEB.

April 20, 2001

How Cancer Control Grants, Contracts Distributed By States

October 13, 1978

Flexibility OK In Paying Grants If Justified, Upton Affirms

September 1, 1978

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009